Creative Planning Sangamo Therapeutics, Inc Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Creative Planning holds 18,985 shares of SGMO stock, worth $22,022. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,985

Previous 13,985 35.75%

Holding current value

$22,022

Previous $5,000 220.0%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$0.32 - $1.1 $1,600 - $5,500	5,000 Added 35.75%	18,985 $16,000
Q2 2024 Aug 15, 2024	BUY	$0.36 - $0.65 $106 - $191	295 Added 2.15%	13,985 $5,000
Q3 2023 Nov 16, 2023	SELL	$0.58 - $1.47 $580 - $1,470	-1,000 Reduced 6.81%	13,690 $8,000
Q2 2023 Jul 21, 2023	SELL	$1.11 - $1.74 $17,224 - $27,001	-15,518 Reduced 51.37%	14,690 $19,000
Q1 2023 May 15, 2023	BUY	$1.66 - $3.67 $23,518 - $51,996	14,168 Added 88.33%	30,208 $53,000
Q4 2022 Feb 10, 2023	BUY	$2.77 - $5.07 $2,938 - $5,379	1,061 Added 7.08%	16,040 $50,000
Q3 2022 Nov 03, 2022	BUY	$4.27 - $6.39 $593 - $888	139 Added 0.94%	14,979 $73,000
Q1 2022 May 16, 2022	SELL	$5.23 - $7.82 $7,473 - $11,174	-1,429 Reduced 8.78%	14,840 $86,000
Q4 2021 Feb 11, 2022	BUY	$7.29 - $10.97 $4,949 - $7,448	679 Added 4.36%	16,269 $122,000
Q3 2021 Nov 10, 2021	BUY	$9.01 - $12.01 $17,119 - $22,819	1,900 Added 13.88%	15,590 $140,000
Q2 2021 Aug 04, 2021	SELL	$10.17 - $12.64 $21,662 - $26,923	-2,130 Reduced 13.46%	13,690 $164,000
Q3 2020 Nov 05, 2020	BUY	$9.38 - $12.48 $6,566 - $8,736	700 Added 4.63%	15,820 $149,000
Q2 2020 Jul 23, 2020	SELL	$6.21 - $11.83 $724,166 - $1.38 Million	-116,613 Reduced 88.52%	15,120 $135,000
Q1 2020 May 05, 2020	SELL	$5.05 - $8.85 $1.55 Million - $2.71 Million	-306,649 Reduced 69.95%	131,733 $839,000
Q4 2019 Jan 30, 2020	BUY	$8.03 - $11.7 $3.22 Million - $4.69 Million	400,553 Added 1058.85%	438,382 $3.67 Million
Q3 2019 Nov 01, 2019	SELL	$9.05 - $12.22 $156,338 - $211,100	-17,275 Reduced 31.35%	37,829 $342,000
Q2 2019 Jul 26, 2019	BUY	$8.75 - $13.03 $229,818 - $342,232	26,265 Added 91.07%	55,104 $593,000
Q1 2019 Apr 24, 2019	BUY	$7.72 - $12.81 $42,884 - $71,159	5,555 Added 23.86%	28,839 $275,000
Q4 2018 Feb 01, 2019	SELL	$9.51 - $16.6 $97,953 - $170,980	-10,300 Reduced 30.67%	23,284 $267,000
Q3 2018 Oct 25, 2018	BUY	$13.05 - $19.05 $41,381 - $60,407	3,171 Added 10.43%	33,584 $569,000
Q2 2018 Jul 20, 2018	BUY	$13.9 - $19.8 $278,000 - $396,000	20,000 Added 192.07%	30,413 $432,000
Q1 2018 Apr 18, 2018	BUY	$16.7 - $26.35 $173,897 - $274,382	10,413 New	10,413 $198,000

Others Institutions Holding SGMO

# of Institutions

109

Shares Held

56.7M

Call Options Held

576K

Put Options Held

1.17M

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Sangamo Therapeutics, Inc Transaction History